COVID-19 Funding Opportunities
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) View Solicitation
Topic: NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV. NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.
Due Date: Rolling, through February 21, 2021
Budget: Not specified
National Institute of Drug Abuse (NIDA)
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus View Solicitation
Topic: NIDA is interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
Due Date: Rolling, through March 31, 2021
Budget: Maximum of $100,000 direct costs per year for 2 years. Higher budgets may be considered with justification.
National Science Foundation (NSF)
Dear Colleague Letter on the Coronavirus View Letter
The NSF encourages investigators to use existing NSF funding mechanisms to submit proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.
For proposals of up to $200K, NSF encourages using the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency.
Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) View Letter
The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.
Other US Funding Agencies
Medical Technology Enterprise Consortium (MTEC)
MTEC Pre-Announcement for MTEC-20-09-COVID19 – “Prototype Development to Combat COVID-19” View Pre-Announcement
MTEC has issued a pre-announcement to provide notice for the possibility of one or more upcoming RPPs focused on combating COVID-19. The timeline for these RFPs is not yet specified.
Coalition for Epidemic Preparedness Innovation (CEPI) Multi-purpose platform technologies for rapid response against emerging infectious diseases View Solicitations
Topic: Vaccine and adaptive epidemic response platform development
Due Date: Expressions of Interest (EOIs) will be accepted on a rolling basis until October 14, 2020.
Budget: Not specified
Medical CBRN Defense Consortium (MCDC)
Request for Information (RFI) – CoV Pandemic Response View Solicitation
MCDC is requesting proposals regarding rapidly deployable (1-6 months) products and technologies to combat the current pandemic. Longer-term solutions are not requested in this RFI.
Topic: COVID-19-related Diagnostics/Monitoring, Surveillance, Information Systems for Point of Care, Therapeutics, Prophylactics, Clinical Trials
Due Date: 5/31/20
Budget: Not Specified
Sign in with